122 related articles for article (PubMed ID: 30629193)
1. Genetic polymorphisms of ABCB1 (P-glycoprotein) as a covariate influencing daptomycin pharmacokinetics: a population analysis in patients with bone and joint infection.
Bricca R; Goutelle S; Roux S; Gagnieu MC; Becker A; Conrad A; Valour F; Laurent F; Triffault-Fillit C; Chidiac C; Ferry T;
J Antimicrob Chemother; 2019 Apr; 74(4):1012-1020. PubMed ID: 30629193
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of daptomycin in patients with bone and joint infection: minimal effect of rifampicin co-administration and confirmation of a sex difference.
Garreau R; Bricca R; Gagnieu MC; Roux S; Conrad A; Bourguignon L; Ferry T; Goutelle S;
J Antimicrob Chemother; 2021 Apr; 76(5):1250-1257. PubMed ID: 33550409
[TBL] [Abstract][Full Text] [Related]
3. Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients.
Baietto L; D'Avolio A; Cusato J; Pace S; Calcagno A; Motta I; Corcione S; Di Perri G; De Rosa FG
J Antimicrob Chemother; 2015 Jan; 70(1):307-8. PubMed ID: 25239468
[No Abstract] [Full Text] [Related]
4. Influence of ABCB1 (1236C > T, 2677G > T and 3435C > T) polymorphisms on the transport ability of P-gp-mediated sunitinib in Caco-2 cell line.
Tan DQ
Xenobiotica; 2020 Mar; 50(3):346-353. PubMed ID: 31023123
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Drug-Drug Interaction Potential of Daptomycin in Combination with Rifampin in Healthy Adult Volunteers.
Benefield RJ; Slechta ES; Gast CM; Spivak ES; Hanson KE; Alexander DP
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224525
[TBL] [Abstract][Full Text] [Related]
6. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene.
Kimchi-Sarfaty C; Marple AH; Shinar S; Kimchi AM; Scavo D; Roma MI; Kim IW; Jones A; Arora M; Gribar J; Gurwitz D; Gottesman MM
Pharmacogenomics; 2007 Jan; 8(1):29-39. PubMed ID: 17187507
[TBL] [Abstract][Full Text] [Related]
7. Post-mortem analysis of suicide victims shows ABCB1 haplotype 1236T-2677T-3435T as a candidate predisposing factor behind adverse drug reactions in females.
Rahikainen AL; Palo JU; Haukka J; Sajantila A
Pharmacogenet Genomics; 2018 Apr; 28(4):99-106. PubMed ID: 29481489
[TBL] [Abstract][Full Text] [Related]
8. Influence of ABCB1 polymorphisms on the pharmacokinetics and toxicity of lenalidomide in patients with multiple myeloma.
Kobayashi T; Miura M; Abumiya M; Akamine Y; Ito F; Takahashi N
Med Oncol; 2019 May; 36(6):55. PubMed ID: 31089832
[TBL] [Abstract][Full Text] [Related]
9. Impact of gene polymorphisms in drug-metabolizing enzymes and transporters on trough concentrations of rivaroxaban in patients with atrial fibrillation.
Nakagawa J; Kinjo T; Iizuka M; Ueno K; Tomita H; Niioka T
Basic Clin Pharmacol Toxicol; 2021 Feb; 128(2):297-304. PubMed ID: 32920985
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of daptomycin in critically ill patients.
Soraluce A; Asín-Prieto E; Rodríguez-Gascón A; Barrasa H; Maynar J; Carcelero E; Soy D; Isla A
Int J Antimicrob Agents; 2018 Aug; 52(2):158-165. PubMed ID: 29572042
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial.
Jakobsen Falk I; Lund J; Gréen H; Gruber A; Alici E; Lauri B; Blimark C; Mellqvist UH; Swedin A; Forsberg K; Carlsson C; Hardling M; Ahlberg L; Lotfi K; Nahi H
Cancer Chemother Pharmacol; 2018 Jan; 81(1):183-193. PubMed ID: 29177954
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of gabapentin in healthy Korean subjects with influence of genetic polymorphisms of ABCB1.
Tran P; Yoo HD; Ngo L; Cho HY; Lee YB
J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):567-579. PubMed ID: 29018999
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites.
Liu Z; Martin JH; Liauw W; McLachlan SA; Link E; Matera A; Thompson M; Jefford M; Hicks RJ; Cullinane C; Hatzimihalis A; Campbell I; Crowley S; Beale PJ; Karapetis CS; Price T; Burge ME; Michael M
Eur J Clin Pharmacol; 2022 Jan; 78(1):53-64. PubMed ID: 34480602
[TBL] [Abstract][Full Text] [Related]
14. Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantation.
Hu R; Barratt DT; Coller JK; Sallustio BC; Somogyi AA
Pharmacogenet Genomics; 2019 Jan; 29(1):9-17. PubMed ID: 30489455
[TBL] [Abstract][Full Text] [Related]
15. ABCB1 c.2677G>T/c.3435C>T diplotype increases the early-phase oral absorption of losartan.
Shin HB; Jung EH; Kang P; Lim CW; Oh KY; Cho CK; Lee YJ; Choi CI; Jang CG; Lee SY; Bae JW
Arch Pharm Res; 2020 Nov; 43(11):1187-1196. PubMed ID: 33249530
[TBL] [Abstract][Full Text] [Related]
16. ABCB1 Polymorphisms and Cold Pressor Pain Responses: Opioid-Dependent Patients on Methadone Maintenance Therapy.
Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R
Nurs Res; 2017; 66(2):134-144. PubMed ID: 28252574
[TBL] [Abstract][Full Text] [Related]
17. The impact of genetic polymorphisms, diltiazem, and demographic variables on everolimus trough concentrations in lung transplant recipients.
Schoeppler KE; Aquilante CL; Kiser TH; Fish DN; Zamora MR
Clin Transplant; 2014 May; 28(5):590-7. PubMed ID: 24628014
[TBL] [Abstract][Full Text] [Related]
18. Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms.
Favela-Mendoza AF; Rangel-Villalobos H; Fricke-Galindo I; Ortega-Vázquez A; Martínez-Cortés G; López-López M
Mol Biol Rep; 2018 Dec; 45(6):2525-2533. PubMed ID: 30317428
[TBL] [Abstract][Full Text] [Related]
19. Role of the ABCB1 Drug Transporter Polymorphisms in the Pharmacokinetics of Oseltamivir in Humans: a Preliminary Report.
Cha YJ; Ghim JL
J Korean Med Sci; 2017 Sep; 32(9):1542-1547. PubMed ID: 28776352
[TBL] [Abstract][Full Text] [Related]
20. Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients.
Genvigir FD; Salgado PC; Felipe CR; Luo EY; Alves C; Cerda A; Tedesco-Silva H; Medina-Pestana JO; Oliveira N; Rodrigues AC; Doi SQ; Hirata MH; Hirata RD
Pharmacogenet Genomics; 2016 Oct; 26(10):462-72. PubMed ID: 27434656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
